United Healthcare may cover it with prior authorization, while Cigna, Blue Cross Blue Shield, and Aetna also provide policies for eligible patients
Clinical trials show retatrutide produces larger weight loss and HbA1c reductions than its predecessors, though head-to-head long-term safety data remains limited given its recent approval
We set longer horizons, such as 3 months, for other healing
GLP-1 levels in supernatants were expressed as a percentage of total GLP-1, calculated from the GLP-1 concentration measured in supernatants/(GLP-1 concentration in supernatants + lysates) 100
Third-Party Testing: This ensures that what is on the label is actually in the bottle and that the product is free from heavy metals and contaminants
Food and Drug Administration approved a once-daily oral version of Wegovy (semaglutide) in December 2025 for chronic weight management in adults meeting specific clinical criteria